Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients by In 't Hout, Florentien E M, Scheele, Thessa N, Westers, Theresia M, Alhan, Canan, Duetz, Carolien, Cremers, Eline M P, Visser-Wisselaar, Heleen A, Verbrugge, Annelies, Chitu, Dana A, Van der Reijden, Bert A, De Graaf, Aniek O, Van de Loosdrecht, Arjan A, Jansen, Joop H

Get full text

Differential contribution of the immunoreceptor tyrosine‐based inhibitory motifs of human leukocyte‐associated Ig‐like receptor‐1 to inhibitory function and phosphatase recruitment... by Verbrugge, Annelies, Ruiter, Talitha de, Clevers, Hans, Meyaard, Linde

Get full text

Signaling by ITIM-Bearing Receptors by Verbrugge, Annelies, Meyaard, Linde

Get full text

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial by Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., Verbrugge, Annelies, Buitenhuis, Danny, Cunha, Sonia M., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., van de Donk, Niels W.C.J., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja

Get full text

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trialResearch in context by Kaz Groen, Claudia A.M. Stege, Kazem Nasserinejad, Koen de Heer, Roel J.W. van Kampen, Rineke B.L. Leys, Noortje Thielen, Matthijs Westerman, Ka-Lung Wu, Inge Ludwig, Djamila E. Issa, Gerjo A. Velders, Marie-Christiane Vekemans, Gert-Jan Timmers, Fransien de Boer, Lidwine W. Tick, Annelies Verbrugge, Danny Buitenhuis, Sonia M. Cunha, Ellen van der Spek, Esther G.M. de Waal, Maaike Sohne, Pieter Sonneveld, Inger S. Nijhof, Saskia K. Klein, Niels W.C.J. van de Donk, Mark-David Levin, Paula F. Ypma, Sonja Zweegman

Get full text

Lenalidomide with or without Erythropoietin and Granulocyte-Colony Stimulating Factor Shows Efficacy in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndrome with or w... by van de Loosdrecht, Arjan A., Chitu, Dana A, Cremers, Eline MP, Westers, Theresia M, Alhan, Canan, Visser-Wisselaar, Heleen, Verbrugge, Annelies, Muus, Petra, de Greef, Inge, Wijermans, Pierre W, Jansen, Joop H., Klein, Saskia K., Vellenga, Edo, Legdeur, Marie-Cecile, Deenik, Wendy, jongen-Lavrencic, Mojca, van Marwijk-Kooy, Rien, Tanis, Bea, Wegman, Jurgen, van Maanen, Tanja, Ossenkoppele, Gert

Get full text

Leukocyte‐associated Ig‐like receptor‐1 has SH2 domain‐containing phosphatase‐independent function and recruits C‐terminal Src kinase by Verbrugge, Annelies, Rijkers, Eva S. K., Ruiter, Talitha de, Meyaard, Linde

Get full text

The Mouse Homologue of the Leukocyte-Associated Ig-Like Receptor-1 Is an Inhibitory Receptor That Recruits Src Homology Region 2-Containing Protein Tyrosine Phosphatase (SHP)-2, bu... by Lebbink, Robert Jan, de Ruiter, Talitha, Verbrugge, Annelies, Bril, Wendy S, Meyaard, Linde

Get full text

Cleavage of the Actin-capping Protein α-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epi... by Bob van de Water, Ine B. Tijdens, Annelies Verbrugge, Merei Huigsloot, Ashwin A. Dihal, James L. Stevens, Susan Jaken, Gerard J. Mulder

Get full text

Cleavage of the Actin-capping Protein α-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epit... by van de Water, Bob, Tijdens, Ine B., Verbrugge, Annelies, Huigsloot, Merei, Dihal, Ashwin A., Stevens, James L., Jaken, Susan, Mulder, Gerard J.

Get full text